The analysis of Global Domestic General Government Health Expenditure by Country for 2024 showcases significant variations. The United States leads with $9.84 thousand PPP per capita, marking a 13.28% increase year-on-year. Denmark, Luxembourg, and Ireland also show notable figures at $7.49, $7.28, and $6.87 thousand respectively, reflecting strong government investment in healthcare. In contrast, countries like Belarus, Macedonia, and Mauritius sit on the lower end, indicating potential areas for policy improvement.
Year-on-year variations reveal high growth in countries like Cyprus (34.18%), Russia (28.84%), and Uzbekistan (25.99%), suggesting these nations are rapidly increasing their government health expenditure. Conversely, some countries, such as Iran (-3.55%) and Dominica (-2.36%), show negative growth, indicating a decline in funding.
Future trends to watch include a continued focus on healthcare investment in high-growth regions like Europe and Asia-Pacific. Governments in emerging economies are likely to boost their health expenditure further, driven by increased awareness and economic capacity. Monitoring the impact of these investments on healthcare outcomes will be critical for future policy formulation.
Top countries in Domestic General Government Health Expenditure by Country
| # | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 9,840 | 2023 | +12.12% | +13.28% | View data |
| 2 | 2 Denmark | 7,490 | 2023 | +10.21% | +8.99% | View data |
| 3 | 3 Luxembourg | 7,280 | 2023 | +6.17% | +6.66% | View data |
| 4 | 4 Ireland | 6,870 | 2023 | +9.26% | +9.59% | View data |
| 5 | 5 United Kingdom | 6,750 | 2023 | +11.51% | +12.83% | View data |
| 6 | 6 Germany | 6,310 | 2023 | +4.85% | +5.21% | View data |
| 7 | 7 Norway | 6,170 | 2023 | +1.86% | +0.51% | View data |
| 8 | 8 Sweden | 5,920 | 2023 | +2.89% | +3.47% | View data |
| 9 | 9 Austria | 5,570 | 2023 | +4.35% | +4.83% | View data |
| 10 | 10 Iceland | 5,180 | 2023 | +5% | +5.61% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
